Glycosaminoglycan in articular cartilage

In vivo assessment with delayed Gd(DTPA)2- -enhanced MR imaging

I. Adil Bashir, Martha L. Gray, Robert D Boutin, Deborah Burstein

Research output: Contribution to journalArticle

380 Citations (Scopus)

Abstract

PURPOSE: To investigate the feasibility of applying magnetic resonance (MR) imaging with use of an anionic compound, Gd(DTPA)2- (gadolinium diethylenetriamine-pentaacetic acid), for measuring glycosaminoglycan concentration in human cartilage in clinical studies. MATERIALS AND METHODS: Penetration of Gd(DTPA)2- into cartilage was monitored through sequential T1-calculated images obtained after intraarticular (n = 2) or intravenous (n = 2) injection. T1-weighted and T1-calculated image series were then obtained in seven volunteers (nine knees) after penetration of Gd-(DTPA)2- into cartilage. If T1 was heterogeneous on Gd(DTPA)2--enhanced images, images were also obtained after penetration of the cartilage with the nonionic contrast agent, gadoteridol. RESULTS: Gd(DTPA)2- penetrated cartilage from the articular surface after intraarticular injection and from both the articular surface and the subchondral bone after intravenous injection. The latter resulted in shorter overall penetration time. T1 values on Gd(DTPA)2--enhanced images were homogeneous in four knees, but in five knees T1 differences of up to 30% were observed. These T1 differences were not seen in the presence of gadoteridol. These variations in T1 reflected about 50% variations in glycosaminoglycan. CONCLUSION: The data suggest that Gd(DTPA)2--enhanced MR imaging has potential for monitoring glycosaminoglycan content of cartilage in vivo.

Original languageEnglish (US)
Pages (from-to)546-550
Number of pages5
JournalRadiology
Volume205
Issue number2
StatePublished - 1997
Externally publishedYes

Fingerprint

Gadolinium DTPA
Articular Cartilage
Glycosaminoglycans
Magnetic Resonance Imaging
Cartilage
Knee
Intra-Articular Injections
Pentetic Acid
Gadolinium
Intravenous Injections
Contrast Media
Volunteers
Joints
Bone and Bones
Injections

Keywords

  • 4521.12143
  • 4521.77
  • 4521.91
  • Arthritis
  • Cartilage
  • Contrast enhancement
  • Degenerative
  • Gadolinium
  • Gadoteridol
  • Magnetic resonance (MR)

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Glycosaminoglycan in articular cartilage : In vivo assessment with delayed Gd(DTPA)2- -enhanced MR imaging. / Adil Bashir, I.; Gray, Martha L.; Boutin, Robert D; Burstein, Deborah.

In: Radiology, Vol. 205, No. 2, 1997, p. 546-550.

Research output: Contribution to journalArticle

Adil Bashir, I. ; Gray, Martha L. ; Boutin, Robert D ; Burstein, Deborah. / Glycosaminoglycan in articular cartilage : In vivo assessment with delayed Gd(DTPA)2- -enhanced MR imaging. In: Radiology. 1997 ; Vol. 205, No. 2. pp. 546-550.
@article{95c27ab5e9c34f059693b1e4f265fe5d,
title = "Glycosaminoglycan in articular cartilage: In vivo assessment with delayed Gd(DTPA)2- -enhanced MR imaging",
abstract = "PURPOSE: To investigate the feasibility of applying magnetic resonance (MR) imaging with use of an anionic compound, Gd(DTPA)2- (gadolinium diethylenetriamine-pentaacetic acid), for measuring glycosaminoglycan concentration in human cartilage in clinical studies. MATERIALS AND METHODS: Penetration of Gd(DTPA)2- into cartilage was monitored through sequential T1-calculated images obtained after intraarticular (n = 2) or intravenous (n = 2) injection. T1-weighted and T1-calculated image series were then obtained in seven volunteers (nine knees) after penetration of Gd-(DTPA)2- into cartilage. If T1 was heterogeneous on Gd(DTPA)2--enhanced images, images were also obtained after penetration of the cartilage with the nonionic contrast agent, gadoteridol. RESULTS: Gd(DTPA)2- penetrated cartilage from the articular surface after intraarticular injection and from both the articular surface and the subchondral bone after intravenous injection. The latter resulted in shorter overall penetration time. T1 values on Gd(DTPA)2--enhanced images were homogeneous in four knees, but in five knees T1 differences of up to 30{\%} were observed. These T1 differences were not seen in the presence of gadoteridol. These variations in T1 reflected about 50{\%} variations in glycosaminoglycan. CONCLUSION: The data suggest that Gd(DTPA)2--enhanced MR imaging has potential for monitoring glycosaminoglycan content of cartilage in vivo.",
keywords = "4521.12143, 4521.77, 4521.91, Arthritis, Cartilage, Contrast enhancement, Degenerative, Gadolinium, Gadoteridol, Magnetic resonance (MR)",
author = "{Adil Bashir}, I. and Gray, {Martha L.} and Boutin, {Robert D} and Deborah Burstein",
year = "1997",
language = "English (US)",
volume = "205",
pages = "546--550",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - Glycosaminoglycan in articular cartilage

T2 - In vivo assessment with delayed Gd(DTPA)2- -enhanced MR imaging

AU - Adil Bashir, I.

AU - Gray, Martha L.

AU - Boutin, Robert D

AU - Burstein, Deborah

PY - 1997

Y1 - 1997

N2 - PURPOSE: To investigate the feasibility of applying magnetic resonance (MR) imaging with use of an anionic compound, Gd(DTPA)2- (gadolinium diethylenetriamine-pentaacetic acid), for measuring glycosaminoglycan concentration in human cartilage in clinical studies. MATERIALS AND METHODS: Penetration of Gd(DTPA)2- into cartilage was monitored through sequential T1-calculated images obtained after intraarticular (n = 2) or intravenous (n = 2) injection. T1-weighted and T1-calculated image series were then obtained in seven volunteers (nine knees) after penetration of Gd-(DTPA)2- into cartilage. If T1 was heterogeneous on Gd(DTPA)2--enhanced images, images were also obtained after penetration of the cartilage with the nonionic contrast agent, gadoteridol. RESULTS: Gd(DTPA)2- penetrated cartilage from the articular surface after intraarticular injection and from both the articular surface and the subchondral bone after intravenous injection. The latter resulted in shorter overall penetration time. T1 values on Gd(DTPA)2--enhanced images were homogeneous in four knees, but in five knees T1 differences of up to 30% were observed. These T1 differences were not seen in the presence of gadoteridol. These variations in T1 reflected about 50% variations in glycosaminoglycan. CONCLUSION: The data suggest that Gd(DTPA)2--enhanced MR imaging has potential for monitoring glycosaminoglycan content of cartilage in vivo.

AB - PURPOSE: To investigate the feasibility of applying magnetic resonance (MR) imaging with use of an anionic compound, Gd(DTPA)2- (gadolinium diethylenetriamine-pentaacetic acid), for measuring glycosaminoglycan concentration in human cartilage in clinical studies. MATERIALS AND METHODS: Penetration of Gd(DTPA)2- into cartilage was monitored through sequential T1-calculated images obtained after intraarticular (n = 2) or intravenous (n = 2) injection. T1-weighted and T1-calculated image series were then obtained in seven volunteers (nine knees) after penetration of Gd-(DTPA)2- into cartilage. If T1 was heterogeneous on Gd(DTPA)2--enhanced images, images were also obtained after penetration of the cartilage with the nonionic contrast agent, gadoteridol. RESULTS: Gd(DTPA)2- penetrated cartilage from the articular surface after intraarticular injection and from both the articular surface and the subchondral bone after intravenous injection. The latter resulted in shorter overall penetration time. T1 values on Gd(DTPA)2--enhanced images were homogeneous in four knees, but in five knees T1 differences of up to 30% were observed. These T1 differences were not seen in the presence of gadoteridol. These variations in T1 reflected about 50% variations in glycosaminoglycan. CONCLUSION: The data suggest that Gd(DTPA)2--enhanced MR imaging has potential for monitoring glycosaminoglycan content of cartilage in vivo.

KW - 4521.12143

KW - 4521.77

KW - 4521.91

KW - Arthritis

KW - Cartilage

KW - Contrast enhancement

KW - Degenerative

KW - Gadolinium

KW - Gadoteridol

KW - Magnetic resonance (MR)

UR - http://www.scopus.com/inward/record.url?scp=33748502934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748502934&partnerID=8YFLogxK

M3 - Article

VL - 205

SP - 546

EP - 550

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -